HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yanxia Liu Selected Research

apratoxin A

11/2011Systematic Chemical Mutagenesis Identifies a Potent Novel Apratoxin A/E Hybrid with Improved in Vivo Antitumor Activity.
7/2009Apratoxin a reversibly inhibits the secretory pathway by preventing cotranslational translocation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yanxia Liu Research Topics

Disease

27Neoplasms (Cancer)
03/2022 - 08/2003
8Inflammation (Inflammations)
01/2020 - 09/2013
5Fibrosis (Cirrhosis)
01/2021 - 01/2017
4Infections
01/2022 - 08/2014
4Neoplasm Metastasis (Metastasis)
01/2021 - 11/2019
4COVID-19
01/2021 - 01/2020
4Vomiting
08/2003 - 01/2002
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 11/2019
3Lung Neoplasms (Lung Cancer)
01/2022 - 06/2015
3Aneuploidy (Aneuploid)
11/2021 - 12/2019
3Atherosclerosis
01/2020 - 09/2015
3Stomach Neoplasms (Stomach Cancer)
01/2019 - 01/2012
2Hepatocellular Carcinoma (Hepatoma)
03/2022 - 09/2011
2Circulating Neoplastic Cells
11/2021 - 12/2019
2Hypoxia (Hypoxemia)
01/2021 - 02/2017
2Esophageal Squamous Cell Carcinoma
10/2020 - 11/2016
2Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases)
01/2020 - 01/2015
2Carcinoma (Carcinomatosis)
01/2020 - 01/2018
2Alzheimer Disease (Alzheimer's Disease)
08/2018 - 12/2012
2Neurodegenerative Diseases (Neurodegenerative Disease)
08/2018 - 01/2008
2Leukemia
01/2018 - 04/2016
2Vesicular Stomatitis
01/2006 - 01/2006
2Nausea
08/2003 - 01/2003
1Type 2 Diabetes Mellitus (MODY)
03/2022
1Epilepsy (Aura)
12/2021
1Hypogonadism (Hypergonadotropic Hypogonadism)
11/2021
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021
1Lung Injury
01/2021
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021
1Signet Ring Cell Carcinoma
01/2021
1Adenocarcinoma
08/2020
1Cerebral Palsy (Spastic Diplegia)
08/2020
1Glaucoma
01/2020
1Insulin Resistance
01/2020
1Vaginal Discharge
01/2020

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2006
7Pharmaceutical PreparationsIBA
01/2020 - 08/2003
5Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2012
4Bevacizumab (Avastin)FDA Link
01/2022 - 01/2011
4Serotonin (5 Hydroxytryptamine)IBA
08/2003 - 01/2002
3LigandsIBA
01/2021 - 11/2011
3MicroRNAs (MicroRNA)IBA
01/2015 - 08/2014
3Cisplatin (Platino)FDA LinkGeneric
08/2003 - 01/2002
2Histone Deacetylases (Histone Deacetylase)IBA
03/2022 - 11/2010
2RNA (Ribonucleic Acid)IBA
01/2022 - 01/2015
2Interleukin-6 (Interleukin 6)IBA
01/2021 - 01/2020
2Indicators and Reagents (Reagents)IBA
01/2021 - 01/2021
2Fluorouracil (Carac)FDA LinkGeneric
10/2020 - 11/2016
2Carotenoids (Carotene)IBA
10/2020 - 11/2016
2VimentinIBA
01/2020 - 12/2019
2CytokinesIBA
01/2020 - 11/2016
2Transcription Factors (Transcription Factor)IBA
01/2019 - 03/2007
2Actin Depolymerizing Factors (Cofilins)IBA
01/2018 - 04/2016
2Messenger RNA (mRNA)IBA
01/2018 - 09/2008
2Neutralizing AntibodiesIBA
01/2018 - 01/2006
2HMGB1 Protein (HMG1)IBA
02/2017 - 11/2016
2Biological ProductsIBA
04/2016 - 08/2014
2Histones (Histone)IBA
08/2014 - 11/2010
2largazoleIBA
08/2014 - 11/2010
2apratoxin AIBA
11/2011 - 07/2009
2Sunitinib (Sutent)FDA Link
09/2011 - 01/2011
2Sorafenib (BAY 43-9006)FDA Link
09/2011 - 01/2011
1XanthonesIBA
03/2022
1Lipid NanoparticlesIBA
01/2022
1Circular RNAIBA
01/2022
1Pilocarpine (Ocusert)FDA LinkGeneric
12/2021
1Testosterone (Sustanon)FDA Link
11/2021
1Long Noncoding RNAIBA
11/2021
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2021
1Alanine Transaminase (SGPT)IBA
01/2021
1Small Interfering RNA (siRNA)IBA
01/2021
1Sucrose (Saccharose)IBA
01/2021
1CateninsIBA
01/2021
1Hyaluronic Acid (Hyaluronan)IBA
01/2021
1Complement System Proteins (Complement)IBA
01/2021
1Recombinant ProteinsIBA
01/2021
1Botulinum Toxins (Botulinum Toxin)IBA
08/2020
1eperisoneIBA
08/2020
1BaclofenFDA LinkGeneric
08/2020
1SiliconesIBA
01/2020
1Bimatoprost (Lumigan)FDA Link
01/2020
1oxidized low density lipoproteinIBA
01/2020
1VaccinesIBA
01/2020
1C-Reactive ProteinIBA
01/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020
1Anti-Obesity Agents (Antiobesity Drugs)IBA
01/2020
1LipopolysaccharidesIBA
01/2020
1Antiviral Agents (Antivirals)IBA
01/2020
1NivolumabIBA
01/2020
1parthenolideIBA
01/2020
1micheliolideIBA
01/2020
1InflammasomesIBA
01/2020

Therapy/Procedure

6Therapeutics
11/2021 - 11/2010
2Drug Therapy (Chemotherapy)
11/2021 - 01/2018
2Immunotherapy
01/2020 - 11/2019
1Lasers (Laser)
01/2021
1Prostatectomy (Retropubic Prostatectomy)
08/2020
1Cystectomy
08/2020
1Contact Lenses
01/2020
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2020